METHOD FOR TREATING UNDERACTIVE BLADDER SYNDROME

摘要

Disclosed are nonlimiting embodiments comprising novel methods for treating underactive bladder in a subject, including administering an effective amount of a pharmaceutical composition comprising an M1-selective muscarinic agonist to the subject. In some embodiments, the M1-selective muscarinic agonist is cevimeline.